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Contribution of different local vascular responses
to mid-gestational vasodilation
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t
n
c
tOBJECTIVE: At-term pregnancy-induced vasodilation is the resultant of
endothelium-dependent vasodilation, decreased myogenic reactivity,
increased compliance, and reduced sensitivity to vasoconstrictor
agents. We hypothesized that these vascular changes are already pres-
ent at mid-gestation.
STUDY DESIGN: In 20 mid-pregnant and 20 nonpregnant Wistar Han-
nover rats, we measured vascular responses of isolated mesenteric ar-
teries and kidney.
RESULTS: In the pregnant rats compared with the nonpregnant rats,
mesenteric flow-mediated vasodilation and renal perfusion flow in-
creased 1.52-fold (from 47 5 to 31 4L/min) and 1.13-fold (from
2.8 0.1 to 14.4 0.1 mL/min), respectively. Nitric oxide inhibition
Gynecol 2011;205:155.e12-17.
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155.e12 American Journal of Obstetrics& Gynecology AUGUST 2011educed mesenteric flow-mediated vasodilation to a similar extent in
he pregnant and nonpregnant rats; it completely blocked the preg-
ancy-induced increase in renal perfusion flow. Pregnancy did not
hange mesenteric artery sensitivity to phenylephrine, myogenic reac-
ivity, nor vascular compliance.
CONCLUSION: At mid-gestation, alterations in rat mesenteric vascular
tone depend primarily on flow-mediated endothelium-dependent
changes and not on changes in -adrenergic vasoconstrictor sensitiv-
ity, myogenic reactivity, or vascular compliance.
Key words: flow-mediated vasodilation, mid-pregnancy, myogenic
reactivity, phenylephrine, vascular complianceCite this article as: van Drongelen J, Pertijs J, Wouterse A. et al. Contribution of different local vascular responses to mid-gestational vasodilation. Am J Obsteto
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dVasodilation in both human
1 and
rat2 pregnancy is already maximal
t mid-gestation. Under physiologic
onditions in nonpregnant subjects, the
enal and mesenteric vascular beds re-
eive approximately 25% and 30%, re-
pectively, of total cardiac output.3,4
During pregnancy, renal plasma flow
(RPF) increases by 40% and mesenteric
perfusion increases by 65%.1,5 Based on
large body of at-term data, vascular ad-
ptation to pregnancy is thought to be
he result of stimulation of the endo-
helium-dependent nitric oxide (NO)
athway,6 reduced responsiveness to va-
oconstrictive stimuli,7 decreased myo-
enic reactivity,8 and increased vascular
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Authorship and contribution to the article is limit
outside funding or technical assistance with thecompliance,8 all of which are responses
hat are likely to interfere with each
ther. In contrast, data on mid-gesta-
ional isolated vessel function are lim-
ted. It has been suggested that some of
hese responses may not be affected at
id-term,9,10 despite the fully vasodi-
ated state.
Relaxin, a member of the insulin-like
rowth factor superfamily, is thought
o mediate the vasodilation of preg-
ancy.11,12 In nonpregnant rats, relaxin
simulates the local and systemic vascular
adaptations that are present at mid-ges-
tation.13,14 Relaxin neutralizing antibod-
es reverse the renal compensatory vas-
ular changes inmid-pregnancy.15 These
ogy (Drs van Drongelen, Lotgering, and
d Toxicology (Dr Smits andMs Pertijs and
ine (Dr Sweep andMrHermsen), Radboud
The Netherlands.
epted March 8, 2011.
nt of Obstetrics and Gynecology 791,
ox 9101, 6500 HB Nijmegen, The
o the 8 authors indicated. There was no
duction of this article./j.ajog.2011.03.020bservations suggest a pivotal role of re-
axin in gestational vascular adaptation.
We hypothesized that mid-gestational
asodilation in rats is mediated by the
p-regulation of endothelium-depen-
ent vasodilation and alteration of vaso-
onstrictor agent sensitivity, myogenic
eactivity, and vascular compliance that
s observed at term. To this end, we in-
estigated vascular function in rats in
oth isolated mesenteric arteries and
idney, because these vascular beds
trongly determine peripheral resistance
uring pregnancy.
MATERIALS AND METHODS
The experimental protocol was ap-
proved by the Animal Experiments
Committee of the Radboud University
Nijmegen Medical Centre and was per-
formed in accordance to the European
guidelines on animal experiments. Forty
female virgin Wistar Hannover rats
(Harlan Netherlands BV, Horst, The
Netherlands) were studied in 2 groups at
an age of 8-10 weeks, followed by 1-week
acclimatization. Group 1 (mid-pregnant
rats, 10; nonpregnant, 10) was used forcol
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www.AJOG.org Basic Science: Obstetrics Researchgraph; group 2 (mid-pregnant rats, 10;
nonpregnant rats, 10) was used for per-
fusion-pressure myograph experiments.
We used the isolated perfused rat kidney
model for experiments on both groups
(n 40).Wehoused all rats by 2 in filter-
op cages on a 12/12-hour light/dark
ycle and provided them with standard
iet (ssniff R/M-H; Ssniff Spezialdieten
mbH, Soest, Germany) and water ad
ibitum. Pregnancywas accomplished by
ating with an experiencedmale of sim-
lar age. The presence of a semen plug
t the bottom of the cage was consid-
red successful mating and day 1 of
regnancy. Mid-pregnant (mid-gesta-
ion, day 11 of the pregnancy) and non-
regnant animals were anesthetizedwith
n intraperitoneal injection of 6 mg/100
pentobarbital (Apharmo, Arnhem,
he Netherlands). Furosemide (1 mg/
00 g; Sigma-Aldrich Chemie BV,
TABLE 1
Baseline vascular characteristics o
arteries in nonpregnant and pregna
Variable Nonpregna
Flow-mediated vasodilation
..........................................................................................................
L-NAME absence
.................................................................................................
Basal diameter, m 274  10
.................................................................................................
Preconstriction, % 41  2
..........................................................................................................
L-NAME presence
.................................................................................................
Basal diameter, m 274  11
.................................................................................................
Preconstriction, % 35  1
...................................................................................................................
Myogenic reactivity
..........................................................................................................
Basal diameter, m 275  8
..........................................................................................................
Preconstriction, % 41  3
...................................................................................................................
Vascular compliance: basal
diameter, m
275  8
...................................................................................................................
Response to phenylephrine
..........................................................................................................
L-NAME absence
.................................................................................................
Basal diameter, m 262  16
.................................................................................................
KCl contraction, mN 13.9 0
..........................................................................................................
L-NAME presence
.................................................................................................
Basal diameter, m 258  10
.................................................................................................
KCl contraction, mN 13.1 0
...................................................................................................................
KCl, potassium chloride; L-NAME, N-nitro-L-arginine methyl e
a Data are given as mean SEM.
van Drongelen. Local vascular responses in mid-gestationwijndrecht, The Netherlands) was in-jected intraperitoneally to achieve maxi-
mal urethral distention for optimal cath-
eter placement. We weighed all animals
before surgery. During surgery, blood
was withdrawn and plasma was stored at
–80°C to measure relaxin concentration
with a homologous radioimmunoas-
say. The assay was performed according
to the method of Sherwood and Crne-
kovic.16 In our hands, the analytic
ensitivity of the assay was 0.51 ng/mL.
ilution experiments showed good par-
llelism in the range of 25–100 L.
Flow-mediated vasodilation, myo-
genic reactivity to pressure, and compli-
ance were analyzed in a pressure-perfu-
sion myograph (Pressure Myograph
System-Model P100; J. P. Trading, Aar-
hus, Denmark). The responses were
determined in phosphate-buffered sa-
line solution (119 mmol/L NaCl, 4.69
mmol/L KCl, 25 mmol/L NaHCO3, 1.17
esenteric
rats
ratsa n Pregnanta n
..................................................................................................................
..................................................................................................................
8 268  7 9
..................................................................................................................
8 36  1 9
..................................................................................................................
..................................................................................................................
7 265  9 7
..................................................................................................................
7 32  2 7
..................................................................................................................
..................................................................................................................
10 270  7 7
..................................................................................................................
10 45  3 7
..................................................................................................................
10 273  7 10
..................................................................................................................
..................................................................................................................
..................................................................................................................
8 252  10 10
..................................................................................................................
8 13.2  1.0 10
..................................................................................................................
..................................................................................................................
9 263  10 10
..................................................................................................................
9 12.4  0.7 10
..................................................................................................................
sodilation. Am J Obstet Gynecol 2011.mmol/L MgSO4, 1.18 KH2PO4, 5.5
AUGUST 2011 Americanmmol/L glucose, and 10 mmol/L
HEPES), to which were added 2mmol/L
ethylene glycol tetraacetic acid and 0.01
mmol/L Na-Nitroprusside (for calcium-
free phosphate-buffered saline solution)
to measure compliance or 2.5 mmol/L
CaCl2, 0.027 mmol/L Na2 ethylene di-
amine tetraacetic acid (for calciumphos-
phate-buffered saline solution) to assess
flow-mediated vasodilation and myo-
genic reactivity. The buffers were oxy-
genated with 95% O2 and 5% CO2 at
a temperature of 37°C. Second-order
mesenteric arteries (150-400 m) were
mounted on 2 opposing glass cannulas
(125 m). Vascular inner diameter was
easured through video recording (Ves-
el View; J. P. Trading). Arteries were
quilibrated at an intraluminal pressure
f 60 mm Hg for 20 minutes. Subse-
uently, preconstrictionwas achieved by
he addition of the thromboxane A2 ag-
nist, U46619 (9,11-Dideoxy-11, 9-
epoxymethanoprostaglandin F2; Sig-
a-Aldrich Chemie BV, Zwijndrecht,
he Netherlands; bath concentration of
0–710–6 mol/L), thereby reducing the
essel diameter by 30-40% of their basal
iameter.
Flow-mediated vasodilation was de-
ned as the vasodilator response to a cer-
ain blood flow increase. After reaching a
table contraction, the blood flow in the
essel was increased by 16.7-L/min
teps (2-minute interval) from 0-100
L/min (comparable with a shear-stress
range of 0-10 dyne/cm2), in the absence
r presence of 100 mol/L of the NO
ntagonist L-NAME (L-Nitro-Arginine
Methyl Ester; Sigma-Aldrich Chemie
BV). Meanwhile, the intraluminal pres-
sure was maintained at 60 mm Hg. Ves-
sels were excluded from the study if they
attained 20% preconstriction, 10%
vasodilation over the completed flow-
range, or instable pressure because of
fluid leakage. Flow-mediated vasodila-
tion was expressed as a percentage of the
preconstriction status.
Myogenic reactivity was defined as the
asoconstrictive response to a certain
ressure increase in the presence of cal-
ium. Compliance was defined as the va-
sodilator response to a certain pressure
increase in the absence calcium, to avoidf m
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ster.smooth muscle cell contraction. To
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Research Basic Science: Obstetrics www.AJOG.orgwithdraw interference of previous as-
sessments, a new mesenteric vessel was
isolated and prepared as described ear-
lier. Intraluminal pressure was increased
every 2 minutes by 10-mm Hg steps,
from 20 mm Hg up to 110 mm Hg, to
successively determine myogenic reac-
tivity and compliance (expressed in mi-
crometer, m).
We studied the vasoconstrictor re-
ponse to phenylephrine (Sigma-Aldrich
hemie BV) with a Mulvany Halpern
yograph (Dual Wire Myograph-
odel 400A; J. P. Trading). The bathwas
lled with physiologic salt solution (119
mol/L NaCl, 4.69 mmol/L KCl, 2.5
mol/L CaCl2, 25 mmol/L NaHCO3,
.17 mmol/L MgSO4, 1.18 KH2PO4, 5.5
mol/L glucose and 0.027 mmol/L eth-
lene diamine tetraacetic acid) and oxy-
enated with 95% O2 and 5% CO2 at a
temperature of 37°C. Four second-order
mesenteric arteries (150-400 m) were
mounted in 2 wire myographs, which
were stabilized as previously described,17
and set at a tension equivalent to that
generated at 90% of the inner circumfer-
ence at 100 mmHg. The response to 124
mmol/L KCl wasmeasured to allow nor-
malization of the phenylephrine re-
sponse. The response to phenylephrine
was determined in 8 steps over a range
from 10–7-10–5 mol/L, in the absence or
presence of 100 mol/L L-NAME. The
ata for the 2 arteries in each myograph
ere averaged when available.
The intrinsic adaptation of the kidney
as assessed in the isolated perfused rat
idney model. Within the time frame of
ur protocol, this model was known to
epresent stable renal function.18 Briefly,
he right renal artery was cannulated
hrough the left renal artery and aorta. The
ight ureter was cannulated for urine col-
ection. Perfusion was started in situ, and
he kidney was removed and placed in a
erfused bath at a temperature of 37.5°C.
he kidney was perfused at a constant
ressure of 90 mm Hg with oxygenated
ell-free Krebs-Ringer-Henseheit (which
ontained 113 mmol/L NaCl, 4.8 mmol/L
CL, 25 mmol/L NaHCO3, 1.4 mmol/L
KH2PO4, 2.2 mmol/L CaCl2, 1.4 mmol/
MgCl2, 5 mmol/L glucose), 1.7 mmol/L
luronic F-108 (oxygen carrier and on-
otic agent; BASF, Arnhem, The Neth- c
155.e14 American Journal of Obstetrics& Gynecorlands). Renal perfusion flow (RPFF)
as recorded real-time with the use of
computer system (Midac testorga-
izer, W95 [version 3.0]; Radboud
niversity Nijmegen Medical Centre,
he Netherlands).
Stabilization of the RPFF was ac-
FIGURE 1
Flow-mediated vasodilator respons
Flow-mediated vasodilator response inmesenteri
rats in absence (n 9 and 8, respectively) and p
n 7 and 7, respectively). Responses were perfo
(in the absence of N-nitro-L-arginine methyl es
reconstriction to U46619 in nonlinear regressio
amount of flow that induces a 50% response (Flo
he section symbol (§) denotes the significant d
van Drongelen. Local vascular responses in mid-gestational vomplished during a 40-minute pe- m
logy AUGUST 2011iod. From 40-60 minutes, the basal
PFF (RPFFbaseline) was determined. At
0 minutes L-NAME was added to the
perfusate (achieving a concentration of
100mol/L) to investigate the contribu-
ion of NO to the relaxin- (or placebo-)
voked vasodilator response up to 160
teries in mid-pregnant (P ) and nonpregnant (NP )
nce of N-nitro-L-arginine methyl ester (L-NAME;
ed in pressure-perfusion myograph experiments
. Vasodilation is displayed as a percentage of
rves at the left side of the figure. The derivative
%) is presented in the bar graph on the right side.
ence within the weight group (P .05).
ilation. Am J Obstet Gynecol 2011.e
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www.AJOG.org Basic Science: Obstetrics Researchfor bodyweight (milliliters perminute per
100 grams of body weight).
The data were expressed as means
standard error of the mean (SEM); n
indicates the number of animals. Flow-
mediated vasodilation, response to
phenylephrine, and RPFF were analyzed
by nonlinear regression curve fitting
FIGURE 2
Myogenic reactivity and complianc
Myogenic reactivity (closed circles [pregnant rats
compliance (closed squares [pregnant rats, 10];
arteries in mid-pregnant and nonpregnant rats. T
perfusion myograph experiments. Differences we
rection for percentage preconstriction for myoge
van Drongelen. Local vascular responses in mid-gestational v
TABLE 2
Phenylephrine response curve-fit e
Variable Nonpregnant rat
C50%, mol/L..........................................................................................................
Without L-NAME 1.74  0.12
..........................................................................................................
With L-NAME 1.26  0.11
...................................................................................................................
Rmax, %..........................................................................................................
Without L-NAME 114  4
..........................................................................................................
With L-NAME 128  6
...................................................................................................................
Phenylephrine response curve-fit estimates of the wire myo
absence and presence of 100 mol/L N-nitro-L-arginine met
phenylephrine induction at a 50% response (C50%) and the
response to 124 mmol/L potassium chloride.
a Values presented as means SEM.van Drongelen. Local vascular responses in mid-gestational va(GraphPad Prism 4.0; Institute for Sci-
entific Information, San Diego, CA).
Subsequent curve fit estimates were (1)
maximal vascular diameter after flow
change (Diammax), (2) flow rate induc-
ng 50% dilation, (3) flow-sensitivity
Flow50%), (4) maximum response to
phenylephrine, and (5) phenylephrine
7]; open circles [nonpregnant rats (NP ), 10]) and
n squares [nonpregnant rats, 10]) in mesenteric
esponse to pressure was evaluated in pressure-
tested by repeated measurement analyses (cor-
reactivity).
ilation. Am J Obstet Gynecol 2011.
mates
n Pregnant ratsa n
..................................................................................................................
9 1.91  0.13 10
..................................................................................................................
9 1.20  0.08 10
..................................................................................................................
..................................................................................................................
9 118  4 10
..................................................................................................................
9 120  4 10
..................................................................................................................
h experiments in nonpregnant and pregnant rats in the
ster (L-NAME), with an estimation of the concentration of
mum response (Rmax) as a percentage of the maximumt
sodilation. Am J Obstet Gynecol 2011.
AUGUST 2011 Americanconcentration that induced a 50% re-
sponse (C50%), RPFFbaseline, andRPFFbaseline
minus RPFF160 (RPFFdelta). Overall
yogenic reactivity (corrected for per-
entage preconstriction) and overall vas-
ular compliance were analyzed by anal-
sis of variance for repeated measures
Greenhouse-Geisser correction; ver-
ion 16.0.2; SPSS Inc, Chicago, IL). Se-
ective straight-line curve fittingwas per-
ormed over the range of 60–110 mm
g, for both myogenic reactivity and
ompliance to estimate the hill slope.
aseline characteristics were analyzed
ith the Student t test. A probability
alue of  .05 was considered to repre-
ent statistical significance.
RESULTS
The studypopulation contained 20preg-
nant and 20 nonpregnant female virgin
Wistar Hannover rats with amean age of
94 2 days. Consistent in all experimen-
tal settings, pregnant rats were approxi-
mately 7% heavier at mid-pregnancy
than nonpregnant rats (246 3 vs 229
4 g; P  .01). At mid-gestation, plasma
relaxin levels were higher than in non-
pregnant animals (2.4 0.3 vs 1.1 0.1
g/mL; P .01). Baseline characteristics
f isolated mesenteric arteries (basal di-
meter, percentage preconstriction to
46619, and vasoconstrictor response to
24 mmol/L KCl) were comparable in
oth groups (Table 1).
Figure 1 represents the flow-mediated
asodilator response and corresponding
urve-fit estimates. At mid-gestation,
regnancy increased sensitivity to flow
decreased Flow50%) 1.52-fold (from
75 to314L/min;P .05)without
altering maximal reactivity (Diammax
29  2% and 24  2% in pregnant and
nonpregnant rats, respectively). NO-
blockade reduced maximal reactivity
(Diammax) in both pregnant and non-
regnant rats by 21 1% and 20 4%,
espectively, although a difference in
ow sensitivity persisted (Flow50%, 24
4 and 57  10 L/min in pregnant and
nonpregnant rats, respectively; P .05).
his indicates that the up-regulation of
ow-mediated vasodilation at mid-ges-
ation does not depend on stimulation ofe
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maxihe NO pathway.
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Research Basic Science: Obstetrics www.AJOG.orgFigure 2 shows myogenic reactivity
nd vascular compliance. Pregnancy did
either affect myogenic reactivity (over-
ll myogenic vascular compliance [P 
.19] andmyogenic reactivity at60mm
Hg [–2  2 vs –2  2 m/10 mm Hg])
or vascular compliance (overall vascu-
ar compliance [P  .56] and vascular
ompliance at60mmHg [3 2 vs 3
m/10 mm Hg]). Table 2 depicts the
curve-fit estimates of the response to
phenylephrine. Both sensitivity (C50%)
and maximum response to phenyleph-
rine were comparable among pregnant
and nonpregnant rats. L-NAME in-
reased sensitivity (reduced C50%) to a
imilar degree in both pregnant and
onpregnant rats.
Figure 3 details the RPFF response
urves of pregnant and nonpregnant
ats. Pregnancy increased RPFFbaseline
1.13-fold (from 12.8 0.1 to 14.4 0.1
mL/min; P  .05) and RPFFdelta (NO-
dependent vasodilation) 1.23-fold (from
6.5 0.2 to 8.0 0.2 mL/min; P .05).
COMMENT
The present study investigated the extent
to which each of the independent local
responses in isolated mesenteric arteries
and kidney in rats contributed to mid-
pregnancy vasodilation.We showed that
mid-gestation is characterized by en-
hanced flow-mediated (endothelium-
dependent) vasodilation and not by a
concomitant increase in vascular com-
pliance, reduced -adrenergic vasocon-
strictor agent sensitivity, ormyogenic re-
activity. As such, our observations at
mid-term differ from those observed at
term.
In contrast to vascular adaptation in
rats at term, mid-term local vascular ad-
aptation seems to rely on endothelium-
dependent changes only. Our study does
not allow direct comparison of vascular
responses at mid-term and term.We did
not include a group of rats at term, be-
cause this has already been investigated
in extent. However, our findings are in
line with those of others, who reported
that early pregnancy increased (endo-
thelium-dependent) responsiveness to
acetylcholine19 and blood flow.20 Appar-
ntly, in contrast to observations in rats e
155.e16 American Journal of Obstetrics& Gynecot term,21 at mid-term the increased re-
sponsiveness to flow ofmesenteric arter-
ies does not depend on NO up-regula-
tion. We speculate that prostaglandins
and endothelium-derived hyperpolariz-
ing factor also contribute to mid-gesta-
tional vasodilation. As observed by oth-
ers at mid-term, we did not detect
pregnancy-induced changes in sensitiv-
ity to phenylephrine.9 Possibly because
of strain differences, and in contrast to
others, we did not find changes in vascu-
lar compliance.8 Although we did not in-
vestigate other vasoconstrictor agents, our
data imply that mid-gestational vasodila-
tion directly relates to endothelium-
dependent vascular adjustment and not
to changes in smooth muscle cell or ex-
tracellular matrix function.
In vivo data report that RPF increases
approximately 1.4-fold in both humans
and rodents at mid-term.1,22 After isola-
ion, RPFF increases only 1.13-fold. The
ifferencemaybe the consequence of de-
letion of humoral and autonomic con-
rol in ex vivo, compared with in vivo,
FIGURE 3
Renal perfusion flow in IPRK
Renal perfusion flow (RPFF ) in response to 100
0 minutes) in mid-pregnant (P 16; closed squ
ats. The responses were analyzed in isolated pe
van Drongelen. Local vascular responses in mid-gestational vxperiments. However, one may address
logy AUGUST 2011he effects of impaired oxygen delivery,
hich is associated with whole organ
erfusion, on renal function. Because we
ptimized oxygen-delivery by using the
xygen-carrier Pluronic, it seems un-
ikely that hypoxia-induced changes are
esponsible for our findings.Our data on
PFF in the isolated rat kidney seem to
e in linewith in vivo observations 23 and
in isolated renal arteries24 at mid-term,
in that the gestational rise in RPFF is
completely NO-dependent. As far as we
know, there are no comparable studies
that have used the isolated rat kidney
model. Our findings show that, in an iso-
lated setting, the intrinsic NO-depen-
dentmodifications account for only 13%
of mid-gestational renal adaptation. The
decrease of mid-term renal vasodilata-
tion, as observed in vivo, can be ac-
counted for in the in vitro setting itself
and subsequent depletion of humoral
and autonomic factors.
Our data supply insight in different
types of vascular responses that are in-
volved in mid-gestational local vascular
ol/L N-nitro-L-arginine methyl ester (L-NAME; at
s) and nonpregnant (NP; n 13; open squares)
sed rat kidney (IPRK ) experiments.
ilation. Am J Obstet Gynecol 2011.m
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www.AJOG.org Basic Science: Obstetrics Researchlimitations must be addressed. First, we
have not randomized rats that did and
did not conceive, which may have led to
selection bias. Because the Wistar Han-
nover rat is known to be a uniform out-
bred line with high reproductive quali-
ties,25 we think that it is unlikely that this
ay have affected our results. Second,
e did not schedule experiments of non-
regnant rats at a particular estrous
tage. Although not visible in our results,
his could have led to heterogeneity and
ncreased variability of the nonpregnant
roup.
Changes in endothelium, smooth mus-
le cell, and extracellular matrix function
ediate gestational vasodilation. Endo-
helium-dependent adaptation involves
he up-regulation of 3 parallel mecha-
isms that concern the stimulation of
O,6 endothelium-derived hyperpolar-
zing factor,26 and prostaglandin27,28
pathways. Possibly depending on the
type of vascular bed, 1 pathway predom-
inateswhile the others fulfill a supportive
role. This may explain the persistence of
increased flow-mediated vasodilation
under NO-blockade, as we observed.
Smooth muscle cell adaptation in preg-
nancy dependsmainly on these endothe-
lium changes,29 although matrix metal-
loproteases enhance extracellular matrix
elasticity.30
There is evidence to suggest that re-
laxin is an important factor involved in
gestational up-regulation of endothelial-
dependent vasodilation andmatrix met-
allopreateases.11,31 Because we detected
only a small increase in relaxin levels at
mid-gestation, we speculate that low levels
of relaxin mainly enhance endothelium-
dependent vasodilation. As pregnancy
proceeds to term, both flow-mediated
changes and higher levels of relaxin may
promote vessel-remodeling and reduce
smooth-muscle cell reactivity.
In summary, these in vitro experiments
suggest that, in rats, vasodilation inmesen-
teric arteries at mid-gestation is mediated
mainly by an increase in flow-mediated
(endothelium-dependent) changes and
not by adjustment of -adrenergic vaso-
constrictor sensitivity, myogenic reactiv-
ity, or vascular compliance. fACKNOWLEDGMENTS
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